Nikanjam, Mina http://orcid.org/0000-0001-7052-6348
Capparelli, Edmund V.
Lancet, Jeffrey E.
Louie, Arthur
Schiller, Gary
Funding for this research was provided by:
Tower Cancer Research Foundation
National Institutes of Health (1U54HD090259-01)
Aramont Foundation for the study of Hematological Malignancies
Article History
Received: 10 July 2017
Accepted: 15 November 2017
First Online: 22 November 2017
Compliance with ethical standards
:
: Dr. Capparelli serves on the data safety and monitoring board for Cempra Pharmaceuticals and The Medicines Company and has received consulting fees from Aptose, Plexxikon, Atox Bio Ltd, Celltrion, and Patara. Dr. Schiller has received research funding from Celator Pharmaceuticals. Dr. Louie is employed by Celator Pharmaceuticals.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.